Genomic Profiling

Physicians can now take advantage of a new genetic test—one of the earliest of its kind to be offered in the United States—that can help determine the best treatment for cancer patients, which is one major goal of personalized genomic medicine. Genomics and Pathology Services at Washington University School of Medicine in St. Louis (GPS@WUSTL) now offers a test that can examine 46 genes for mutations that reveal abnormalities in a tumor’s cellular machinery. This information can be used by oncologists treating a variety of different types of tumors and blood cancers. GPS@WUSTL testing also supports the discovery of new genetic markers through clinical research collaborations in oncology and other areas.

Visit gps.wustl.edu or call (314) 747-7337.

Innovate, winter 2013